Literature DB >> 31879333

Intra-Arterial Verapamil Treatment in Oral Therapy-Refractory Reversible Cerebral Vasoconstriction Syndrome.

J M Ospel1, C H Wright2, R Jung3, L L M Vidal4, S Manjila5, G Singh6, D V Heck7, A Ray8, K A Blackham9.   

Abstract

Reversible vasoconstriction syndrome is a complex of clinical symptoms and angiographic findings, which, while having a mostly benign clinical course, has clinical and imaging overlap with more serious disorders such as vasculitis and aneurysmal SAH and itself includes a minority of patients with fulminant vasoconstriction resulting in severe intracranial complications. Endovascular options for patients with refractory reversible cerebral vasoconstriction syndrome include intra-arterial vasodilator infusion similar to therapy for patients with vasospasm after SAH. To date, only case reports and 1 small series have discussed the utility of intra-arterial vasodilators for the treatment of reversible cerebral vasoconstriction syndrome. We report an additional series of 11 medically refractory cases of presumed or proved reversible cerebral vasoconstriction syndrome successfully treated with intra-arterial verapamil infusion. Furthermore, we propose that the reversal of vasoconstriction, as seen on angiography, could fulfill a diagnostic criterion.
© 2020 by American Journal of Neuroradiology.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31879333      PMCID: PMC7015224          DOI: 10.3174/ajnr.A6378

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  38 in total

1.  Reversible segmental cerebral vasoconstriction (Call-Fleming syndrome): are calcium channel inhibitors a potential treatment option?

Authors:  D A Nowak; S O Rodiek; S Henneken; J Zinner; R Schreiner; H-H Fuchs; H Topka
Journal:  Cephalalgia       Date:  2003-04       Impact factor: 6.292

Review 2.  Narrative review: reversible cerebral vasoconstriction syndromes.

Authors:  Leonard H Calabrese; David W Dodick; Todd J Schwedt; Aneesh B Singhal
Journal:  Ann Intern Med       Date:  2007-01-02       Impact factor: 25.391

Review 3.  Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-04-10       Impact factor: 3.825

4.  Magnetic resonance angiography in reversible cerebral vasoconstriction syndromes.

Authors:  Shih-Pin Chen; Jong-Ling Fuh; Shuu-Jiun Wang; Feng-Chi Chang; Jiing-Feng Lirng; Ying-Chen Fang; Ben-Chang Shia; Jaw-Ching Wu
Journal:  Ann Neurol       Date:  2010-05       Impact factor: 10.422

Review 5.  The Typical Thunderclap Headache of Reversible Cerebral Vasoconstriction Syndrome and its Various Triggers.

Authors:  Anne Ducros; Valérie Wolff
Journal:  Headache       Date:  2016-03-26       Impact factor: 5.887

6.  Glucocorticoid-associated worsening in reversible cerebral vasoconstriction syndrome.

Authors:  Aneesh B Singhal; Mehmet A Topcuoglu
Journal:  Neurology       Date:  2016-12-09       Impact factor: 9.910

7.  Clinical worsening in reversible cerebral vasoconstriction syndrome.

Authors:  Brian S Katz; Jennifer E Fugate; Sebastián F Ameriso; Virginia A Pujol-Lereis; Jay Mandrekar; Kelly D Flemming; David F Kallmes; Alejandro A Rabinstein
Journal:  JAMA Neurol       Date:  2014-01       Impact factor: 18.302

8.  The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients.

Authors:  Anne Ducros; Monique Boukobza; Raphaël Porcher; Mariana Sarov; Dominique Valade; Marie-Germaine Bousser
Journal:  Brain       Date:  2007-11-19       Impact factor: 13.501

9.  Ultrahigh-dose intraarterial infusion of verapamil through an indwelling microcatheter for medically refractory severe vasospasm: initial experience. Clinical article.

Authors:  Erminia Albanese; Antonino Russo; Monica Quiroga; Rhett N Willis; Robert A Mericle; Arthur J Ulm
Journal:  J Neurosurg       Date:  2010-10       Impact factor: 5.115

Review 10.  Posterior reversible encephalopathy syndrome during systemic lupus erythematosus: four new cases and review of the literature.

Authors:  G Leroux; J Sellam; N Costedoat-Chalumeau; D Le Thi Huong; A Combes; N Tieulié; J Haroche; Z Amoura; A Nieszkowska; J Chastre; D Dormont; J-C Piette
Journal:  Lupus       Date:  2008-02       Impact factor: 2.911

View more
  2 in total

1.  Quantifying Intra-Arterial Verapamil Response as a Diagnostic Tool for Reversible Cerebral Vasoconstriction Syndrome.

Authors:  J M Sequeiros; J A Roa; R P Sabotin; S Dandapat; S Ortega-Gutierrez; E C Leira; C P Derdeyn; G Bathla; D M Hasan; E A Samaniego
Journal:  AJNR Am J Neuroradiol       Date:  2020-09-17       Impact factor: 3.825

Review 2.  Reversible cerebral vasoconstriction syndrome: review of neuroimaging findings.

Authors:  Teresa Perillo; Chiara Paolella; Giulia Perrotta; Antonietta Serino; Ferdinando Caranci; Andrea Manto
Journal:  Radiol Med       Date:  2022-08-06       Impact factor: 6.313

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.